HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoyuki Yamamoto Selected Research

Hypoglycemic Agents (Hypoglycemics)

11/2012Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoyuki Yamamoto Research Topics

Disease

7Type 2 Diabetes Mellitus (MODY)
01/2013 - 01/2008
6Neoplasms (Cancer)
11/2015 - 08/2009
4Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 08/2011
3Body Weight (Weight, Body)
01/2013 - 07/2012
3Hypoglycemia (Reactive Hypoglycemia)
11/2012 - 07/2012
3Diabetic Nephropathies (Diabetic Nephropathy)
03/2012 - 01/2006
3Proteinuria
03/2012 - 01/2007
3Hypertension (High Blood Pressure)
05/2011 - 01/2003
2Rectal Neoplasms (Rectal Cancer)
11/2014 - 04/2011
2Hypersensitivity (Allergy)
12/2012 - 07/2012
2IGA Glomerulonephritis (IGA Nephropathy)
03/2012 - 01/2006
2Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
03/2012 - 01/2006
2Membranous Glomerulonephritis (Membranous Nephropathy)
01/2007 - 01/2006
1Seasonal Affective Disorder
01/2020
1Avian Sarcoma
01/2019
1Infections
01/2019
1Hepatocellular Carcinoma (Hepatoma)
12/2014
1Acanthosis Nigricans
03/2014
1Diabetes Mellitus
03/2014
1Papilloma (Papillomatosis)
03/2014
1Virus Diseases (Viral Diseases)
11/2013
1Lymphatic Metastasis
11/2013
1Hypercholesterolemia
05/2013
1Atherosclerosis
05/2013
1Insulin Resistance
01/2013
1Weight Loss (Weight Reduction)
01/2013
1Inflammation (Inflammations)
06/2012
1Fibrosis (Cirrhosis)
03/2012
1Carcinoma (Carcinomatosis)
09/2011
1Neoplasm Metastasis (Metastasis)
09/2011
1Adenoma (Adenomas)
09/2011
1Colonic Neoplasms (Colon Cancer)
05/2011
1Wilms Tumor (Wilm's Tumor)
01/2009
1Hypertrophy
01/2009
1Diabetes Complications
07/2008
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2008

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2006
6Insulin (Novolin)FDA Link
03/2014 - 01/2008
5CEACAM1 ProteinIBA
11/2015 - 08/2011
4Protein Isoforms (Isoforms)IBA
02/2015 - 08/2011
4AntibodiesIBA
12/2014 - 01/2009
4Messenger RNA (mRNA)IBA
11/2013 - 01/2006
3DNA (Deoxyribonucleic Acid)IBA
05/2013 - 08/2009
3Insulin Glargine (Lantus)FDA Link
11/2012 - 07/2012
2Peptides (Polypeptides)IBA
05/2013 - 01/2003
2valyl-prolyl-prolineIBA
05/2013 - 05/2011
2isoleucyl-prolyl-prolineIBA
05/2013 - 05/2011
1AntioxidantsIBA
01/2020
1Fructose-Bisphosphate Aldolase (Aldolase)IBA
01/2019
1cerebellinIBA
01/2019
1Glycoproteins (Glycoprotein)IBA
01/2019
1EpitopesIBA
11/2015
1IntegrinsIBA
11/2015
1Fluorouracil (Carac)FDA LinkGeneric
02/2015
1Carcinoembryonic AntigenIBA
11/2014
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
03/2014
1Keratins (Keratin)IBA
03/2014
1Antiviral Agents (Antivirals)IBA
11/2013
1CytokinesIBA
11/2013
1ChemokinesIBA
11/2013
1Apolipoproteins E (ApoE)IBA
05/2013
1ApolipoproteinsIBA
05/2013
1indolepropanol phosphate (IPP)IBA
05/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2013
1Blood Glucose (Blood Sugar)IBA
01/2013
1LiraglutideFDA Link
01/2013
1AdiponectinIBA
01/2013
1ProinsulinIBA
01/2013
1Membrane Transport Proteins (Biological Pump)IBA
12/2012
1Peptide Hydrolases (Proteases)FDA Link
12/2012
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
12/2012
1Hypoglycemic Agents (Hypoglycemics)IBA
11/2012
1Hemoglobins (Hemoglobin)IBA
11/2012
1Protamines (Protamine Sulfate)FDA Link
11/2012
1Isophane Insulin (NPH Insulin)FDA Link
07/2012
1Long-Acting Insulin (Insulin, Long Acting)FDA Link
07/2012
1ProteomeIBA
07/2012
1Mitogen-Activated Protein KinasesIBA
06/2012
1CreatinineIBA
03/2012
1VimentinIBA
03/2012
1Transcription Factors (Transcription Factor)IBA
03/2012
1Phenobarbital (Luminal)FDA Link
09/2011
1Complementary DNA (cDNA)IBA
08/2011
1Small Interfering RNA (siRNA)IBA
08/2011
1Poly AIBA
05/2011
1Antisense Elements (Genetics)IBA
05/2011
1N-acetyltalosaminuronic acid (NAT)IBA
08/2009
1oxidized low density lipoproteinIBA
01/2009
1LectinsIBA
01/2009
1MicellesIBA
03/2008

Therapy/Procedure

7Therapeutics
11/2012 - 01/2006
2Glycemic Control
07/2012 - 07/2008
1Drug Therapy (Chemotherapy)
02/2015
1Injections
03/2014
1Oral Administration
11/2013
1Aftercare (After-Treatment)
01/2013
1Renal Dialysis (Hemodialysis)
11/2012
1Catheters
04/2011
1Surgical Instruments (Clip)
04/2011